Raloxifene hydrochloride is an oral selective estrogen receptor modulator belonging to the benzothiophene class, indicated for the prevention of osteoporosis in postmenopausal women and the reduction of… Read more
Raloxifene hydrochloride is an oral selective estrogen receptor modulator belonging to the benzothiophene class, indicated for the prevention of osteoporosis in postmenopausal women and the reduction of breast cancer risk. This category features high-quality pharmaceutical reference standards for this active pharmaceutical ingredient, alongside its related impurities and metabolites. These compounds are essential tools for analytical laboratories, supporting critical processes such as impurity profiling, method validation, and rigorous quality control during pharmaceutical manufacturing. By utilizing these precisely characterized reference materials, researchers and quality assurance teams can accurately identify and quantify potential degradants or synthesis byproducts, ensuring compliance with regulatory specifications. Whether for routine testing or complex development studies, these standards, including stable isotope labelled compounds, provide the necessary precision for the evaluation and assurance of drug consistency and safety.